Stanley Laman Group, Ltd. Zoetis Inc. Transaction History

Stanley Laman Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	SELL	$131.14 - $157.47 $38,424 - $46,138	-293 Reduced 14.5%	1,727 $0
Q2 2022 Aug 08, 2022	BUY	$155.97 - $200.09 $315,059 - $404,181	2,020 New	2,020 $347,000
Q4 2020 Feb 09, 2021	SELL	$157.07 - $174.35 $424,089 - $470,745	-2,700 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$137.1 - $165.37 $10,419 - $12,568	76 Added 2.9%	2,700 $446,000
Q2 2020 Jul 20, 2020	BUY	$111.92 - $142.53 $50,140 - $63,853	448 Added 20.59%	2,624 $360,000
Q1 2020 May 12, 2020	BUY	$92.66 - $144.94 $201,628 - $315,389	2,176 New	2,176 $256,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.